C54
Conditions
Interventions
Group 1: Patients being treated for primary endometrial cancer (group A).
All patients answer the same questionnaire, regardless of which arm they are in.
Patients being treated for primary endometria
Sponsors
Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie e.V.
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Diagnosis of endometrial cancer
Exclusion criteria
Exclusion criteria: Patients with other tumors and patients under the age of 18.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Three patient groups will be compared: primary treatment, relapse treatment, and follow-up. The main objective is to assess the frequency of side effects, particularly polyneuropathy and hair loss. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Assess treatment preferences - Evaluate decision-making for appropriate therapies - Assess patient adherence to recommended treatments - Analyse financial burden of the disease and its treatment - Analyse time burden associated with the disease and treatment - Evaluate access to healthcare and support systems - Assess patient education regarding the disease, genetic factors, and therapy options - Evaluate patients’ knowledge of medical guidelines - Analyse the impact of polyneuropathy and hair loss on overall quality of life across the three subgroups | — |
Countries
France, Germany, United Kingdom
Outcome results
None listed